Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City | Zendy

Marina Altagracia-Martı́nez | Zendy; Christian Díaz de León Castañeda | Zendy; Kravzov-Jinich | Zendy; Moreno-Bonett | Zendy; Martínez-Núñez | Zendy; Rosario Cárdenas-Elizalde | Zendy

Open Access

Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City

Author(s) -

Marina Altagracia-Martı́nez,

Christian Díaz de León Castañeda,

Kravzov-Jinich,

Moreno-Bonett,

Martínez-Núñez,

Rosario Cárdenas-Elizalde

Publication year - 2012

Publication title -

clinicoeconomics and outcomes research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.591

H-Index - 27

ISSN - 1178-6981

DOI - 10.2147/ceor.s27826

Subject(s) - medicine , acarbose , metformin , type 2 diabetes , diabetes mellitus , public health , odds ratio , type 2 diabetes mellitus , family medicine , gerontology , environmental health , emergency medicine , endocrinology , nursing

Worldwide, diabetes mellitus presents a high burden for individuals and society. In Latin America, many people with diabetes have limited access to health care, which means that indirect costs may exceed direct health care cost. Diabetes is Mexico's leading cause of death.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research